NT-3 Levels and Function in Individuals With CMT
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Clinical Trials Related to Chronic Inflammatory Demyelinating Polyneuropathy
Related studies linked through entity extraction aliases.
An Expanded Access IND for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Hizentra® in Inflammatory Neuropathies - pHeNIx Study
- Status
- RECRUITING
- Phase
- N/A
Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy
- Status
- WITHDRAWN
- Phase
- PHASE2
A Registered Cohort Study of Immune-Mediated Neuropathies
- Status
- UNKNOWN
- Phase
- N/A
Evaluating the Effectiveness of Telemonitoring System in the Management of Patients With CIDP
- Status
- TERMINATED
- Phase
- N/A
Non-invasive Vagus Nerve Stimulation (nVNS) in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Status
- TERMINATED
- Phase
- NA
Quantification of Nerve Stiffness in Neuropathies
- Status
- COMPLETED
- Phase
- NA
SERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot Study
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy
- Status
- WITHDRAWN
- Phase
- PHASE2
Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Status
- COMPLETED
- Phase
- NA
IVIg Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
- Status
- COMPLETED
- Phase
- N/A
IVIg for Demyelination in Diabetes Mellitus
- Status
- UNKNOWN
- Phase
- PHASE4
Effect of Resistance and Aerobic Exercise in CIDP or MMN
- Status
- COMPLETED
- Phase
- NA
Immunoglobulin Dosage and Administration Form in CIDP and MMN
- Status
- COMPLETED
- Phase
- N/A
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
- Status
- COMPLETED
- Phase
- N/A
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Chronic Inflammatory Demyelinating Polyneuropathy.
- Status
- COMPLETED
- Phase
- PHASE3
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)
- Status
- COMPLETED
- Phase
- PHASE3
Prevalence of Decreased Corneal Sensation in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
- Status
- COMPLETED
- Phase
- N/A
High-dose Cyclophosphamide for Moderate to Severe Refractory Chronic Inflammatory Demyelinating Polyneuropathy
- Status
- WITHDRAWN
- Phase
- PHASE2